Pharmamarketeer

New solution for sleep apnoea

Sleep apnoea

In an Australian world-first, researchers have successfully repurposed two existing medications to reduce the severity of sleep apnoea in people by at least 30 per cent. Affecting millions around the world, sleep apnoea is a condition where the upper airway from the back of the nose to the throat closes repetitively during sleep, restricting oxygen intake and causing people to wake as often as 100 times or more per hour.

Advertentie(s)